SEC Form 4 research

Allogene Therapeutics, Inc. insider transactions

IssuerAllogene Therapeutics, Inc.
TickersALLO
Reporting owners30
Officers and directors18
Last public filing2026-08-26

Recent insider disclosures

AvailableTrade dateReporting ownersCodeSharesPriceReported value
2026-08-252026-08-21Douglas Earl MartinS29,697$2.12Not reported

Officers and directors in the directory

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page